|
SMARCC2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.136220E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.840640E-01 |
| Normal-vs-Stage2 |
7.222400E-02 |
| Normal-vs-Stage3 |
1.029990E-02 |
| Normal-vs-Stage4 |
3.660000E-01 |
| Stage1-vs-Stage2 |
3.488400E-01 |
| Stage1-vs-Stage3 |
7.404300E-02 |
| Stage1-vs-Stage4 |
8.109600E-01 |
| Stage2-vs-Stage3 |
8.327200E-01 |
| Stage2-vs-Stage4 |
3.053200E-01 |
| Stage3-vs-Stage4 |
1.193400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.639010E-01 |
| Normal-vs-AfricanAmerican |
6.237400E-01 |
| Normal-vs-Asian |
7.317800E-01 |
| Caucasian-vs-AfricanAmerican |
1.399770E-01 |
| Caucasian-vs-Asian |
3.486400E-01 |
| AfricanAmerican-vs-Asian |
4.733400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.772200E-02 |
| Normal-vs-Female |
8.884300E-02 |
| Male-vs-Female |
7.363400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.400000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.158800E-01 |
| Normal-vs-Age(61-80Yrs) |
1.604030E-02 |
| Normal-vs-Age(81-100Yrs) |
5.606800E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.637600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.279570E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.765000E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.344400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.403900E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.453700E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.610200E-04 |
| Classical-VS-Follicular |
1.007690E-04 |
| Classical-VS-Other |
3.574800E-01 |
| Classical-VS-Normal |
7.940400E-01 |
| Tall-VS-Follicular |
5.682200E-01 |
| Tall-VS-Other |
7.457400E-01 |
| Tall-VS-Normal |
7.917500E-03 |
| Follicular-VS-Other |
5.825600E-01 |
| Follicular-VS-Normal |
1.038980E-03 |
| Other-VS-Normal |
3.328800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.409900E-02 |
| Normal-vs-N1 |
2.044600E-01 |
| N0-vs-N1 |
5.251000E-01 |
|
|
